* SSEC -0.3%, CSI300 -0.54%
* Hong Kong markets, stock connect morning trade cancelled
* Regional markets track the S&P that hits record highs
BEIJING/SHANGHAI, Aug 19 (Reuters) - China shares slid on
Wednesday after three consecutive sessions of gains, as
investors took profits in healthcare and technology stocks with
** At the midday break, the Shanghai Composite index was
down 0.3% at 3,440.71 points.
** China's blue-chip CSI300 index was down 0.54%, with
its financial sector sub-index lower by 0.62%, the
consumer staples sector was up 0.53%, the real
estate index down 1.05% and the healthcare
sub-index down 2.51%.
** The smaller Shenzhen index was down 0.86%, the
start-up board ChiNext Composite index was weaker by
2.22% and Shanghai's tech-focused STAR50 index was
** Morning trading on Hong Kong's securities market, including
Stock Connect trading and derivatives, was cancelled on
Wednesday due to a typhoon affecting the city, bourse operator
Hong Kong Exchanges and Clearing Ltd (HKEX) 0388.HK said.
** "We can see investors are shifting to value stocks with lower
valuations while some tech and health care stocks are being sold
on concerns over lofty valuations," said Fu Yanping, analyst
with China Galaxy Securities.
** Start-up board led the declines today, as investors are
awaiting the market reaction as new listings will soon debut
under a new IPO system which will see stocks rising or falling
by 20% in a session, Fu added.
** White House Chief of Staff Mark Meadows said no new
high-level talks, related to the trade agreement, have been
scheduled between the United States and China
** Around the region, MSCI's Asia ex-Japan stock index
was firmer by 0.42% while Japan's Nikkei index
was up 0.36%.
** The yuan was quoted at 6.921 per U.S. dollar,
0.02% firmer than the previous close of 6.9222.
** Shares in satellite manufacturer China Spacesat Co Ltd
surged as much as 10% to their highest in nearly
five years on robust northbound inflows in morning trading.
** China Life Insurance Co Ltd dropped as much as
6.6% after dismissing rumors regarding merger of the company
with other insurers.
(Reporting by Zhang Yan in Beijing, Luoyan Liu and Andrew
Galbraith in Shanghai; Editing by Shailesh Kuber)